Thursday - December 11, 2025
FDA Issues Warning Letter to Seaway Pharma
December 10, 2025
WASHINGTON, Dec. 10 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Seaway Pharma Inc. from the Office of Manufacturing Quality:

* * *

Recipient: Venkata R. Gogineni, Ph.D., CEO, Seaway Pharma Inc., 5 County Route 42, Massena, NY 13662, United States

Issuing Office: Office of Manufacturing Quality, United States

Warning Letter 320-26-22

Dear Dr. Gogineni and Mr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products